APA (7th ed.) Citation

ZN, S., A, L., M, S., MP, C., N, S., R, B., . . . TC, L. (2025). Comparison of ciprofloxacin and aminoglycoside susceptibility testing for ceftriaxone non-susceptible Enterobacterales by disk diffusion and VITEK 2 vs. broth microdilution using updated Clinical and Laboratory Standards Institute breakpoints. BMC microbiology, 25(1), 175. https://doi.org/10.1186/s12866-025-03923-7

Chicago Style (17th ed.) Citation

ZN, Sohani, Lieu A, Semret M, Cheng MP, Simic N, Bamba R, Patel M, Lawandi A, and Lee TC. "Comparison of Ciprofloxacin and Aminoglycoside Susceptibility Testing for Ceftriaxone Non-susceptible Enterobacterales by Disk Diffusion and VITEK 2 Vs. Broth Microdilution Using Updated Clinical and Laboratory Standards Institute Breakpoints." BMC Microbiology 25, no. 1 (2025): 175. https://doi.org/10.1186/s12866-025-03923-7.

MLA (9th ed.) Citation

ZN, Sohani, et al. "Comparison of Ciprofloxacin and Aminoglycoside Susceptibility Testing for Ceftriaxone Non-susceptible Enterobacterales by Disk Diffusion and VITEK 2 Vs. Broth Microdilution Using Updated Clinical and Laboratory Standards Institute Breakpoints." BMC Microbiology, vol. 25, no. 1, 2025, p. 175, https://doi.org/10.1186/s12866-025-03923-7.